ArticleOncotarget2015

MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab.

Jitka Mlcochova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.